Heads Up??? I received this email this morning - i own

New Post Public Reply Private Reply Replies (1) Message Board
guidelines
762
Heads Up??? I received this email this morning - i own 46mil shares in what I thought was dead dog - but, look like something big is happening - board lit up starting yesterday. Can any of you team mates translate what you read in this email and the board postings? Plus - IDGC WENT CURRENT PINK THIS AM. It looks like there are plenty of .0001s left.

RE:
Weed2016 Member Level
Thursday, February 9, 2017 11:12:44 PM
IDGC #$$$

MUST READ IDGC SHAREHOLDERS

WE Thought we owned 1 MILLION SHARES OF PYHH
TURNS OUT WE OWN 1 MILLION + 8 MILLION MORE = 9 MILLION TOTAL

PYHH 9 million shares x $0.71 = $6.4 million divided by 5.7 billion shares total = $0.0011 PER SHARE IDGC SHOULD BE TRADING AT

? INVESTMENT HOLDINGS

https://www.otcmarkets.com/ajax/showFinancial...?id=165696

The Company owns 1,000,000 shares of common stock in PYHH. This constitutes a
Level I asset because there are quoted prices for the stock in an active market, and is therefore
valued at $0.15 per share, the market price on the balance sheet date. The company has
recently hired Kyle Charles Young Attorney out of Palm Beach, Florida to assist the company in
deciding a course of action regarding the deposit and sale of the PYHH Shares. These shares
were acquired as compensation from a consulting agreement with PYHH in 5/2013, the
company and Transfer Agent has blocked the legend removal from the certificate and neither
has given a valid legal argument for their actions.
The Company owns 198,385 shares of Series B Convertible Preferred Stock in PHYH. Each
share can be converted into 40 shares of common stock, a total of 7,935,400 common
shares if they were all converted. This constitutes a Level III asset because there are no current
quoted prices for the identical common stock in an active market, and is therefore valued at $0
per common share equivalent, the market price of the common stock on the balance sheet date.
The Company owns 500,000 shares of common stock in Jack Rockwell, Inc. This constitutes a
Level 3 asset because it is a startup private company in which there is no reliable way
to determine the fair market value. The Company invested $25,000 during the three
months ended December 31, 2016 and no fair value adjustments have been made.
The company also has two issued patents with the USPTO and has one IP Valuation on one of
the issued patents valued in excess of $5 million dollars US. The valuation report will be
released with these Q2 Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Can Take Charge in Outset Medical Securities Case

Updated Category News Views 226

Investors Can Take Control in Outset Medical Securities Case Investors seeking justice now have a valuable opportunity to take the lead in a class action lawsuit against Outset Medical, Inc. (NASDAQ: OM). This legal effort arises from claims suggesting that the company may not have been fully transparent about its product marketing and operational practices. Understanding...

Continue Reading
Understanding Market Dynamics for IDEXX Laboratories (IDXX)

Updated Category News Views 140

Insights into IDEXX Laboratories Option Trading In recent times, there has been a notable bearish sentiment among major investors regarding IDEXX Laboratories. Taking a closer look at the trading activities surrounding this stock, our attention shifts towards its options market dynamics. Recent Trading Patterns Analyzing the options history for IDEXX Laboratories (NASDAQ:...

Continue Reading
Upcoming Earnings Reports and Market Insights for Investors

Updated Category News Views 164

Key Companies Reporting Earnings Soon As investors gear up for a busy earnings week, a variety of companies are set to disclose their quarterly results. These reports often provide valuable insights into business performance and market trends. Companies Scheduled to Report Before Market Opens So-Young International Inc (NASDAQ: SY) So-Young is anticipated to announce its...

Continue Reading
Intelligent Alpha Launches Innovative AI-Driven ETF for Investors

Updated Category News Views 269

Welcome to Intelligent Alpha and AI-Driven Investments In today's fast-paced investment world, Doug Clinton, co-founder and Managing Partner at Deepwater Asset Management, has introduced Intelligent Alpha, a groundbreaking investment firm focused on utilizing the power of artificial intelligence. This unique firm distinguishes itself by having an investment committee that...

Continue Reading
Investors of Lineage, Inc. (LINE) Consider Class Action Suit

Updated Category News Views 141

Class Action Lawsuit Against Lineage, Inc. In the financial landscape, every investor hopes to see growth in their investments. However, recent developments with Lineage, Inc. have prompted concern among shareholders. It has come to light that some investors may have sustained losses due to alleged securities fraud surrounding the company's performance. As a result, legal...

Continue Reading